Ulrich Redmann

Title: Ulrich Redmann: Innovator in Antimicrobial Compounds

Introduction

Ulrich Redmann is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of antimicrobial compounds, holding a total of 2 patents. His work focuses on developing innovative solutions to combat various infections.

Latest Patents

Redmann's latest patents include compounds that are effective against dermatophyte infections, particularly those caused by Trichophyton rubrum and mentagrophytes, as well as yeast infections like Candida albicans. One of his notable inventions is the amino-, mercapto-, and -oxy-substituted-phenyl and -phenalkyl imidazoles. These compounds are characterized by a specific formula that allows them to combat bacterial and fungal infections effectively. Another significant patent involves 4-nitroperhydropyrido[1,2-a][1,4]diazepines, which possess antimicrobial activity against both gram-positive and gram-negative bacteria.

Career Highlights

Ulrich Redmann is associated with Schering Aktiengesellschaft, a company known for its focus on pharmaceuticals and healthcare. His work at the company has allowed him to contribute to the development of important antimicrobial agents.

Collaborations

Throughout his career, Redmann has collaborated with esteemed colleagues such as Hans-Joachim Kessler and Peter Strehlke. These collaborations have further enhanced the impact of his research and innovations in the field.

Conclusion

Ulrich Redmann's contributions to antimicrobial compounds highlight his role as an influential inventor in the pharmaceutical industry. His innovative patents continue to play a crucial role in addressing significant health challenges.